The fact is that CBA is no longer a good stock to own as the yield on the current price is too low. As for buying it now, you would need psychic help as there is little to gain & far better prospects elsewhere.
Being able to lock in your profits & move on to other investments seems a good outcome.
The shares have risen nearly 172% in the last 4 & a half years to a point where they are no longer worthwhile keeping for the dividend & the significant chance of a major correction.
What, from now, is the upside potential? Do you really believe the yield will go under 3%? At 3% the price would be $155.00. A 4% yield would mean a share price of $116.25. Conversely, 3.5% yield gives a share price of $132.86. The latter would seem to be more realistic in the current circumstances, but a total market correction would bring it down even further.
Why then would you want to buy at close to $140 when a more realistic price is under $133.00?
- Forums
- ASX - By Stock
- Correction
CBA
commonwealth bank of australia.
Add to My Watchlist
2.81%
!
$185.36

The fact is that CBA is no longer a good stock to own as the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$185.36 |
Change
-5.350(2.81%) |
Mkt cap ! $310.1B |
Open | High | Low | Value | Volume |
$190.50 | $191.06 | $185.36 | $367.6M | 1.971M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4521 | $185.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$185.88 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15 | 185.360 |
18 | 4516 | 185.000 |
1 | 50 | 184.950 |
4 | 383 | 184.500 |
1 | 15 | 184.400 |
Price($) | Vol. | No. |
---|---|---|
185.880 | 70 | 1 |
186.090 | 50 | 1 |
187.000 | 300 | 1 |
187.400 | 5 | 1 |
187.600 | 58 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
CBA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online